Astrocytoma - Pipeline Review, H2 2011

Global Markets Direct
August 31, 2011
152 Pages - SKU: GMD6506158
Generalized Seizures Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Generalized Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Generalized Seizures Global Clinical Trials Review, H2, 2014 provides data on the Generalized Seizures clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Partial Seizure Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
Partial Seizure Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Partial Seizure Global Clinical Trials Review, H2, 2014 provides data on the Partial Seizure clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Brain Cancer - Pipeline Review, H2 2014
7/22/2014 | published by: Global Markets Direct
Brain Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H2 2014’, provides an overview of the Brain Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain  |  read more...
USD 2,000
Brain Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
Brain Cancer Drug Pathway Analyzer 2014 Extra value: One year of free online updates included with this product There are today at least 213 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways  |  read more...
USD 6,746
Brain Tumor - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Brain Tumor - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Brain Tumor - Pipeline Review, H2 2014’, provides an overview of the Brain Tumor’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain  |  read more...
USD 2,000
Anaplastic Astrocytoma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Anaplastic Astrocytoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H2 2014’, provides an overview of the Anaplastic Astrocytoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anaplastic  |  read more...
USD 2,000
Substance (Drug) Abuse - Pipeline Review, H2 2014
7/22/2014 | published by: Global Markets Direct
Substance (Drug) Abuse - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Substance (Drug) Abuse - Pipeline Review, H2 2014’, provides an overview of the Substance (Drug) Abuse’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Brain Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Brain Cancer Drug Pipeline Update 2014 Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases  |  read more...
USD 6,746
Anxiety Disorders - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
Anxiety Disorders - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2014’, provides an overview of the Anxiety Disorders’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anxiety  |  read more...
USD 2,000
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2014’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS)’s  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 500  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!